
Jae W. Lee
Examiner (ID: 7721, Phone: (571)272-9949 , Office: P/1656 )
| Most Active Art Unit | 1656 |
| Art Unit(s) | 1656 |
| Total Applications | 1186 |
| Issued Applications | 830 |
| Pending Applications | 111 |
| Abandoned Applications | 269 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18862295
[patent_doc_number] => 20230416731
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-28
[patent_title] => GENE KNOCKOUT OF VARIANT NRF2 FOR TREATMENT OF CANCER
[patent_app_type] => utility
[patent_app_number] => 17/960210
[patent_app_country] => US
[patent_app_date] => 2022-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35920
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17960210
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/960210 | Gene knockout of variant NRF2 for treatment of cancer | Oct 4, 2022 | Issued |
Array
(
[id] => 20272250
[patent_doc_number] => 12442020
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-10-14
[patent_title] => Materials and methods for treatment of pain related disorders
[patent_app_type] => utility
[patent_app_number] => 17/959089
[patent_app_country] => US
[patent_app_date] => 2022-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 12
[patent_no_of_words] => 42381
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 249
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17959089
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/959089 | Materials and methods for treatment of pain related disorders | Oct 2, 2022 | Issued |
Array
(
[id] => 19747064
[patent_doc_number] => 20250035629
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-01-30
[patent_title] => MR-PROADM MARKER PANELS FOR EARLY DETECTION OF SEPSIS
[patent_app_type] => utility
[patent_app_number] => 18/696730
[patent_app_country] => US
[patent_app_date] => 2022-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13493
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18696730
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/696730 | MR-PROADM MARKER PANELS FOR EARLY DETECTION OF SEPSIS | Sep 27, 2022 | Pending |
Array
(
[id] => 18436476
[patent_doc_number] => 20230183770
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-15
[patent_title] => Enzyme Based System for Production of Messenger RNA with Increased Transfection Efficiency
[patent_app_type] => utility
[patent_app_number] => 17/931352
[patent_app_country] => US
[patent_app_date] => 2022-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8697
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 187
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17931352
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/931352 | Enzyme based system for production of messenger RNA with increased transfection efficiency | Sep 11, 2022 | Issued |
Array
(
[id] => 18808932
[patent_doc_number] => 20230383267
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-30
[patent_title] => Flp-TAL RECOMBINASES
[patent_app_type] => utility
[patent_app_number] => 17/943127
[patent_app_country] => US
[patent_app_date] => 2022-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18263
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17943127
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/943127 | Flp-TAL recombinases | Sep 11, 2022 | Issued |
Array
(
[id] => 18342023
[patent_doc_number] => 11639499
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2023-05-02
[patent_title] => Reverse transcriptase variants
[patent_app_type] => utility
[patent_app_number] => 17/940797
[patent_app_country] => US
[patent_app_date] => 2022-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 17
[patent_no_of_words] => 13668
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 268
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17940797
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/940797 | Reverse transcriptase variants | Sep 7, 2022 | Issued |
Array
(
[id] => 18537798
[patent_doc_number] => 20230242899
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-03
[patent_title] => METHODS AND COMPOSITIONS FOR MODULATING A GENOME
[patent_app_type] => utility
[patent_app_number] => 17/929124
[patent_app_country] => US
[patent_app_date] => 2022-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 142724
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17929124
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/929124 | METHODS AND COMPOSITIONS FOR MODULATING A GENOME | Aug 31, 2022 | Pending |
Array
(
[id] => 18838561
[patent_doc_number] => 11846628
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-12-19
[patent_title] => Organelle-targeted genetically-encoded voltage indicators and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 17/893530
[patent_app_country] => US
[patent_app_date] => 2022-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 6
[patent_no_of_words] => 5613
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 132
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17893530
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/893530 | Organelle-targeted genetically-encoded voltage indicators and methods of use thereof | Aug 22, 2022 | Issued |
Array
(
[id] => 18281902
[patent_doc_number] => 20230097374
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-30
[patent_title] => Recombinant expression platform, constructs and methods for expression of Difficult to Express Proteins (DTE-Ps)
[patent_app_type] => utility
[patent_app_number] => 17/878657
[patent_app_country] => US
[patent_app_date] => 2022-08-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8595
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17878657
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/878657 | Recombinant expression platform, constructs and methods for expression of difficult to express proteins (DTE-PS) | Jul 31, 2022 | Issued |
Array
(
[id] => 18022062
[patent_doc_number] => 20220373561
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-24
[patent_title] => TRANSFORMATIONAL IMMUNE DIAGNOSTICS
[patent_app_type] => utility
[patent_app_number] => 17/816637
[patent_app_country] => US
[patent_app_date] => 2022-08-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16342
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 108
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17816637
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/816637 | TRANSFORMATIONAL IMMUNE DIAGNOSTICS | Jul 31, 2022 | Pending |
Array
(
[id] => 19397290
[patent_doc_number] => 12071641
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-08-27
[patent_title] => RNA-guided nucleases and DNA binding proteins
[patent_app_type] => utility
[patent_app_number] => 17/815453
[patent_app_country] => US
[patent_app_date] => 2022-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 40852
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 640
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17815453
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/815453 | RNA-guided nucleases and DNA binding proteins | Jul 26, 2022 | Issued |
Array
(
[id] => 19258265
[patent_doc_number] => 12018311
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-06-25
[patent_title] => Long chain dibasic acid with low content of long chain dibasic acid impurity of shorter carbon-chain and preparation method thereof
[patent_app_type] => utility
[patent_app_number] => 17/814972
[patent_app_country] => US
[patent_app_date] => 2022-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 12641
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 101
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17814972
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/814972 | Long chain dibasic acid with low content of long chain dibasic acid impurity of shorter carbon-chain and preparation method thereof | Jul 25, 2022 | Issued |
Array
(
[id] => 19474105
[patent_doc_number] => 12104183
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-10-01
[patent_title] => DNase H activity of Neisseria meningitidis Cas9
[patent_app_type] => utility
[patent_app_number] => 17/870336
[patent_app_country] => US
[patent_app_date] => 2022-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 67
[patent_no_of_words] => 22715
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17870336
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/870336 | DNase H activity of Neisseria meningitidis Cas9 | Jul 20, 2022 | Issued |
Array
(
[id] => 18391397
[patent_doc_number] => 20230159615
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-25
[patent_title] => CHIMERIC POLYPEPTIDES
[patent_app_type] => utility
[patent_app_number] => 17/812712
[patent_app_country] => US
[patent_app_date] => 2022-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 153151
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17812712
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/812712 | CHIMERIC POLYPEPTIDES | Jul 13, 2022 | Pending |
Array
(
[id] => 18162491
[patent_doc_number] => 20230029084
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-26
[patent_title] => LACTOBACILLUS PARACASEI TCI727 AND METHOD FOR PROMOTING CALCIUM ABSORPTION BY USING LACTOBACILLUS PARACASEI TCI727/OR ITS METABOLITES
[patent_app_type] => utility
[patent_app_number] => 17/812182
[patent_app_country] => US
[patent_app_date] => 2022-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6139
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17812182
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/812182 | None | Jul 12, 2022 | Issued |
Array
(
[id] => 18267069
[patent_doc_number] => 20230088311
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-23
[patent_title] => RECOGNITION SEQUENCES FOR I-CREI-DERIVED MEGANUCLEASES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/812400
[patent_app_country] => US
[patent_app_date] => 2022-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11132
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17812400
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/812400 | RECOGNITION SEQUENCES FOR I-CREI-DERIVED MEGANUCLEASES AND USES THEREOF | Jul 12, 2022 | Abandoned |
Array
(
[id] => 18620642
[patent_doc_number] => 11753670
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2023-09-12
[patent_title] => Cell-free protein synthesis methods using lysates of yersinia pestis
[patent_app_type] => utility
[patent_app_number] => 17/862495
[patent_app_country] => US
[patent_app_date] => 2022-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6562
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17862495
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/862495 | Cell-free protein synthesis methods using lysates of yersinia pestis | Jul 11, 2022 | Issued |
Array
(
[id] => 18342044
[patent_doc_number] => 11639520
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-05-02
[patent_title] => Compositions of matter for detection assays
[patent_app_type] => utility
[patent_app_number] => 17/861208
[patent_app_country] => US
[patent_app_date] => 2022-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 35487
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 225
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17861208
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/861208 | Compositions of matter for detection assays | Jul 8, 2022 | Issued |
Array
(
[id] => 19368514
[patent_doc_number] => 12060588
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-08-13
[patent_title] => Methods of editing DNA methylation
[patent_app_type] => utility
[patent_app_number] => 17/858758
[patent_app_country] => US
[patent_app_date] => 2022-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 48
[patent_figures_cnt] => 48
[patent_no_of_words] => 32590
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17858758
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/858758 | Methods of editing DNA methylation | Jul 5, 2022 | Issued |
Array
(
[id] => 19297631
[patent_doc_number] => 20240226197
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-11
[patent_title] => METHODS OF TREATING DISEASES AND CONDITIONS, SUCH AS INFLAMMATORY DISEASES, CANCER, CARDIOVASCULAR DISEASE, DIABETES AND OBESITY WITH THE PROBIOTIC LACTOBACILLUS JOHNSONII 456
[patent_app_type] => utility
[patent_app_number] => 17/858364
[patent_app_country] => US
[patent_app_date] => 2022-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3175
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17858364
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/858364 | METHODS OF TREATING DISEASES AND CONDITIONS, SUCH AS INFLAMMATORY DISEASES, CANCER, CARDIOVASCULAR DISEASE, DIABETES AND OBESITY WITH THE PROBIOTIC LACTOBACILLUS JOHNSONII 456 | Jul 5, 2022 | Abandoned |